一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Journal of Crystal Growth >>article
Journal of Crystal Growth

Journal of Crystal Growth

IF: 1.7
Download PDF

Manufacture and characterization of two distinct quasi-polymorphs of empagliflozin

Published:15 March 2020 DOI: 10.1016/j.jcrysgro.2020.125489
Paul Kim , Ga-Young Kim , Min-Yong Cho , Min-Jeong Lee , Guang J. Choi

Abstract

We investigated the polymorphic behaviors of empagliflozin (EMP), an SGLT2 inhibitor focusing on the preparation and characterization of its two distinct quasi-polymorphs combined with in-line monitoring of crystallization processes. EMP has only been reported as a single polymorph without pseudo-polymorphs so far. In this study, two differentiable crystal forms, the needle-shaped ‘Form I’ and platy-shaped ‘Form P’, were reproducibly created using an anti-solvent approach. Although the two forms of EMP yielded the same results in many of these analyses, they could be differentiated by powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), and microscopy. Based on a detailed analysis of DSC thermograms, a small but obvious transition was detected during the melting of crystalline EMP at 152–157?°C. This transition, which occurred at a low activation energy, was identified as a polymorphic transformation from Form P to Form I.

The anti-solvent crystallization process was monitored by in-line NIR absorbance measurements and interpreted using principal component analysis (PCA). The crystal form was dependent on the crystallization solvent. Two different solvent/anti-solvent pairs (ethanol-water and ethanol-hexane) yielded substantially different PCA results, indicating distinct pathways to the creation of each crystal form. Rapid nucleation and high crystal growth rate was achieved by crystallization under Scheme P, which also exhibited fluctuation in its PC score plot. This was associated with reversible polymorphic selection between the two crystal forms during the crystallization of EMP.

Substances (8)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Empagliflozin 864070-44-0 C23H27ClO7 764 suppliers $5.00-$1950.00
Empagliflozin 864070-44-0 C23H27ClO7 764 suppliers $5.00-$1950.00
Empagliflozin 864070-44-0 C23H27ClO7 764 suppliers $5.00-$1950.00
Empagliflozin 864070-44-0 C23H27ClO7 764 suppliers $5.00-$1950.00
Empagliflozin 864070-44-0 C23H27ClO7 - Inquiry
Empagliflozin 864070-44-0 C23H27ClO7 - Inquiry
Empagliflozin 864070-44-0 - Inquiry
Empagliflozin 864070-44-0 - Inquiry

Similar articles

IF:2.7

Synthesis and characterization of a palladium(0) complex with cyclophosphazene bearing two diphenylphosphine ligands and application in Suzuki-Miyaura cross-coupling

Inorganica Chimica Acta Maria das G. de O. e Silva , Carolina Galuppo ,etc Published: 1 October 2018
IF:10.5

Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure

JAMA Network Open Katherine L. Modzelewski, Alexandra Pipilas,etc Published: 2 May 2024
IF:5.7

Key Food Furanones Furaneol and Sotolone Specifically Activate Distinct Odorant Receptors

Journal of Agricultural and Food Chemistry Franziska Haag, Sandra Hoffmann,etc Published: 8 September 2021
顺昌县| 威海市| 项城市| 林口县| 奉节县| 梧州市| 沂南县| 阜平县| 云梦县| 林芝县| 长沙县| 吉木萨尔县| 叙永县| 合山市| 莱阳市| 萨迦县| 龙岩市| 竹山县| 张掖市| 黄大仙区| 怀集县| 衡阳县| 师宗县| 海晏县| 元朗区| 延安市| 司法| 文安县| 武邑县| 澎湖县| 木里| 沐川县| 澄迈县| 涟水县| 延庆县| 航空| 神木县| 威海市| 义乌市| 榆社县| 淅川县|